Ignite Creation Date:
2024-05-05 @ 10:37 PM
Last Modification Date:
2024-10-26 @ 10:21 AM
Study NCT ID:
NCT01146574
Status:
COMPLETED
Last Update Posted:
2024-03-01
First Post:
2010-06-16
Brief Title:
A Phase 2a Study To Evaluate The Pharmacokinetics Safety Efficacy Tolerability And Pharmacodynamics of Sotatercept ACE-011 for the Correction of Anemia in Subjects With End-stage Renal Disease on Hemodialysis
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
ACE-011-REN-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Acceleron Pharma Inc a wholly-owned subsidiary of Merck Co Inc Rahway NJ USA | INDUSTRY |